Through PEPFAR, the USG supports a comprehensive package of services to detect, initiate, and suppress the virus in the remaining people living with HIV; as well as to support strengthening laboratory systems, strategic information collection including health management information systems (HMIS), and supply chain management. PEPFAR supported activities are implemented by USAID, HHS/CDC, and DOD with a budget $101 million for FY19, and $115 million planned for FY20. The policy and programmatic progress seen in Ethiopia is as a result of the GoE’s commitment to reach epidemic control; as well strong collaboration with civil society organizations (CSOs), and key stakeholders such as UNAIDS, the Global Fund, and WHO. As funding decreases, the program’s focus is on strengthening systems to monitor the epidemic, improve service delivery models, and ensure program sustainability.
From its inception through September 2018460 in Ethiopia, PEPFAR has supported the provision of lifesaving antiretroviral treatment (ART) for 460,564 people (98% of national results) including children. From October 2017 through September 2018 alone, PEPFAR provided HIV testing and counseling services for nearly 5 million men and women including more than 1 million pregnant women, and have identified more than 60,000 new cases. The program also ensured that over 473,015 orphans and vulnerable children as well as their caregivers received critical care and support services.